Market capitalization of BrainStorm Cell Therapeutics (BCLI)

Market cap: ₹0.97 Billion

As of October 2024 BrainStorm Cell Therapeutics has a market cap of ₹0.97 Billion. This makes BrainStorm Cell Therapeutics the world's 9706th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

End of year Market Cap

End of Day market cap according to different sources

On Oct 15th, 2024 the market cap of BrainStorm Cell Therapeutics was reported to be:

₹0.94 Billion

by Yahoo Finance

₹0.94 Billion

by CompaniesMarketCap

₹0.94 Billion

by Nasdaq

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Gilead Sciences GILD	₹9.074 T	931,921.04%	🇺🇸 USA
Cytokinetics CYTK	₹546.57 B	56,039.01%	🇺🇸 USA
Seagen SGEN	₹3.625 T	372,308.22%	🇺🇸 USA
Biogen BIIB	₹2.313 T	237,485.16%	🇺🇸 USA
Agenus AGEN	₹8.48 B	771.21%	🇺🇸 USA
Acceleron Pharma XLRN	₹918.45 B	94,235.27%	🇺🇸 USA